The FDA has placed multiple investigational gene therapy clinical trials on hold, signaling broader platform concerns.

Separately, the FDA on Friday informally requested that Sarepta voluntarily pause shipments of another gene therapy, Elevidys, that is approved to treat a different type of muscular dystrophy and was ...

Sarepta says it will continue to ship Elevidys despite FDA requests that it stop shipments of the Duchenne muscular dystrophy gene therapy, while Verizon tops earnings expectation and raises 2025 ...

Stock futures ticked higher Monday premarket, kicking off a busy week packed with big tech earnings. Here are some of Monday's biggest stock movers: Biggest stock gainers Block (NYSE:XYZ) +9% – Shares ...